Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fauchald

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Transplantation Proceedings|February 1, 1987
Renal transplantation from living donors mismatched for two HLA haplotypesG Sødal, D Albrechtsen, K J Berg, et al.
Transplantation Proceedings|October 1, 1987
Hemolytic anemia in cyclosporine-treated recipients of kidney or heart grafts from donors with minor incompatibility for ABO antigensB G Solheim, D A Albrechtsen, K J Berg, et al.
Diabetologia|August 1, 1991
Long-term metabolic control in recipients of combined pancreas and kidney transplantsH Holdaas, I B Brekke, A Hartmann, et al.
Transplantation|July 29, 1998
Unrelated living donors in 141 kidney transplantations: a one-center studyA Foss, T Leivestad, I B Brekke, et al.
Transplantation Proceedings|October 1, 1984
Cyclosporine in living related and cadaveric renal transplantationD Albrechtsen, G Soedal, K J Berg, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipientsJ M Kovarik, E Rawlings, P Sweny, et al.
Transplantation Proceedings|April 1, 1996
Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantationJ M Kovarik, E Rawlings, P Sweny, et al.
Transplantation|October 15, 1995
Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study periodJ Wahlberg, H E Wilczek, P Fauchald, et al.
Clinical Transplants|September 30, 1999
The national kidney transplant program in Norway still results in unchanged waiting listsO H Bentdal, T Leivestad, P Fauchald, et al.
Journal of Cardiovascular Risk|April 28, 2001
Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline dataH Holdaas, B Fellström, I Holme, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Transplantation Proceedings|February 1, 1987
Renal transplantation from living donors mismatched for two HLA haplotypesG Sødal, D Albrechtsen, K J Berg, et al.
Transplantation Proceedings|October 1, 1987
Hemolytic anemia in cyclosporine-treated recipients of kidney or heart grafts from donors with minor incompatibility for ABO antigensB G Solheim, D A Albrechtsen, K J Berg, et al.
Diabetologia|August 1, 1991
Long-term metabolic control in recipients of combined pancreas and kidney transplantsH Holdaas, I B Brekke, A Hartmann, et al.
Transplantation|July 29, 1998
Unrelated living donors in 141 kidney transplantations: a one-center studyA Foss, T Leivestad, I B Brekke, et al.
Transplantation Proceedings|October 1, 1984
Cyclosporine in living related and cadaveric renal transplantationD Albrechtsen, G Soedal, K J Berg, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipientsJ M Kovarik, E Rawlings, P Sweny, et al.
Transplantation Proceedings|April 1, 1996
Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantationJ M Kovarik, E Rawlings, P Sweny, et al.
Transplantation|October 15, 1995
Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study periodJ Wahlberg, H E Wilczek, P Fauchald, et al.
Clinical Transplants|September 30, 1999
The national kidney transplant program in Norway still results in unchanged waiting listsO H Bentdal, T Leivestad, P Fauchald, et al.
Journal of Cardiovascular Risk|April 28, 2001
Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline dataH Holdaas, B Fellström, I Holme, et al.
Pageof 14